Koninklijke Philips N.V. (PHG) P/E Ratio History
UndervaluedTrading at 23.1x vs 5Y avg 42.4x · 20th percentile · Below historical baseline · Data 2001–2026
Loading P/E history...
P/E Ratio Analysis
As of September 24, 2026, Koninklijke Philips N.V. (PHG) trades at a price-to-earnings ratio of 23.1x, with a stock price of $24.45 and trailing twelve-month earnings per share of $1.15.
The current P/E is 46% below its 5-year average of 42.4x. Over the past five years, PHG's P/E has ranged from a low of 7.0x to a high of 170.4x, placing the current valuation at the 20th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, PHG is roughly in line with its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 167.0x.
Relative to the broader market, PHG trades roughly in line with the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PHG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PHG Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
PHG P/E vs Peers
Imaging, radiation, and oncology devices peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $105B | 32.5 | 2.19Best | +8% | |
| $66B | 23.0 | - | +55%Best | |
| $50B | 47.4 | 6.70 | -74% | |
| $18B | 25.6 | - | -20% | |
| $115B | 23.9 | 3.42 | +3% | |
| $332B | 39.2 | 3.32 | +36% | |
| $30B | 14.5Lowest | - | +5% | |
| $5B | 52.1 | 9.06 | -38% | |
| $141B | 50.6 | 2.33 | +23% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
PHG Historical P/E Data (2001–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $27.19 | $1.16 | 23.4x | -35% |
| FY2026 Q1 | - | $27.40 | $1.01 | 27.1x | -24% |
| FY2025 Q4 | Dec 31 2025 | $27.08 | $0.93 | 29.1x | -19% |
| FY2025 Q3 | - | $27.26 | $0.16 | 170.4x | +374% |
| FY2025 Q2 | Jun 30 2025 | $23.98 | $0.17 | 141.1x | +293% |
| FY2025 Q1 | Mar 31 2025 | $25.40 | $0.40 | 63.5x | +77% |
| FY2022 Q2 | - | $21.53 | $3.09 | 7.0x | -81% |
| FY2022 Q1 | - | $28.26 | $3.27 | 8.6x | -76% |
| FY2021 Q4 | Dec 31 2021 | $34.11 | $3.47 | 9.8x | -73% |
| FY2021 Q3 | - | $41.13 | $3.93 | 10.5x | -71% |
| FY2021 Q2 | Jun 30 2021 | $46.00 | $1.18 | 39.0x | +9% |
| FY2021 Q1 | Mar 31 2021 | $52.79 | $1.24 | 42.6x | +19% |
| FY2020 Q4 | - | $50.14 | $1.24 | 40.4x | +13% |
| FY2020 Q3 | Sep 30 2020 | $43.64 | $1.19 | 36.7x | +2% |
| FY2020 Q2 | - | $43.35 | $1.06 | 40.9x | +14% |
| FY2020 Q1 | - | $36.43 | $1.09 | 33.4x | -7% |
| FY2019 Q4 | - | $44.27 | $1.22 | 36.3x | +1% |
| FY2019 Q3 | Sep 30 2019 | $41.85 | $1.32 | 31.7x | -12% |
| FY2019 Q2 | Jun 30 2019 | $39.53 | $1.39 | 28.4x | -21% |
| FY2019 Q1 | Mar 31 2019 | $37.07 | $1.33 | 27.9x | -22% |
| FY2018 Q4 | Dec 31 2018 | $31.85 | $1.28 | 24.9x | -31% |
| FY2018 Q3 | Sep 30 2018 | $41.29 | $1.45 | 28.5x | -21% |
| FY2018 Q2 | Jun 30 2018 | $38.35 | $1.47 | 26.1x | -27% |
| FY2018 Q1 | Mar 31 2018 | $34.75 | $1.53 | 22.7x | -37% |
| FY2017 Q4 | Dec 31 2017 | $34.29 | $1.64 | 20.9x | -42% |
| FY2017 Q3 | Sep 30 2017 | $37.38 | $1.42 | 26.3x | -27% |
| FY2017 Q2 | Jun 30 2017 | $32.49 | $1.49 | 21.8x | -39% |
| FY2017 Q1 | Mar 31 2017 | $29.13 | $1.67 | 17.4x | -51% |
| FY2016 Q4 | Dec 31 2016 | $27.73 | $1.47 | 18.9x | -47% |
| FY2016 Q3 | Sep 30 2016 | $26.84 | $0.79 | 33.9x | -6% |
| FY2016 Q2 | - | $22.62 | $0.73 | 30.9x | -14% |
| FY2016 Q1 | - | $25.90 | $0.58 | 44.5x | +24% |
| FY2015 Q4 | - | $23.09 | $0.65 | 35.3x | -2% |
| FY2015 Q3 | Sep 30 2015 | $21.28 | $0.84 | 25.3x | -29% |
| FY2015 Q2 | - | $23.10 | $0.41 | 56.3x | +57% |
| FY2015 Q1 | - | $25.71 | $0.37 | 69.5x | +93% |
| FY2014 Q4 | Dec 31 2014 | $26.31 | $0.41 | 64.2x | +79% |
| FY2014 Q3 | - | $28.77 | $0.68 | 42.3x | +18% |
| FY2014 Q2 | Jun 30 2014 | $28.81 | $1.08 | 26.7x | -26% |
| FY2014 Q1 | Mar 31 2014 | $31.90 | $1.17 | 27.3x | -24% |
| FY2013 Q4 | - | $33.54 | $1.19 | 28.2x | -22% |
| FY2013 Q3 | Sep 30 2013 | $29.26 | $0.42 | 69.7x | +94% |
| FY2013 Q2 | Jun 30 2013 | $24.67 | $0.23 | 107.3x | +199% |
| FY2012 Q4 | Dec 31 2012 | $24.08 | $0.09 | 267.6x | +645% |
| FY2012 Q3 | Sep 30 2012 | $21.27 | $0.29 | 73.3x | +104% |
| FY2012 Q2 | Jun 30 2012 | $17.84 | $0.27 | 67.3x | +87% |
| FY2011 Q1 | - | $29.18 | $1.38 | 21.1x | -41% |
| FY2010 Q4 | Dec 31 2010 | $27.85 | $1.45 | 19.2x | -47% |
| FY2010 Q3 | - | $28.41 | $1.24 | 22.9x | -36% |
| FY2010 Q2 | Jun 30 2010 | $27.07 | $0.90 | 30.1x | -16% |
| FY2010 Q1 | Mar 31 2010 | $29.05 | $0.70 | 41.7x | +16% |
| FY2009 Q4 | - | $26.71 | $0.44 | 61.1x | +70% |
| FY2008 Q3 | - | $24.72 | $2.15 | 11.5x | -68% |
| FY2008 Q2 | Jun 30 2008 | $30.66 | $2.36 | 13.0x | -64% |
| FY2008 Q1 | Mar 31 2008 | $34.78 | $3.00 | 11.6x | -68% |
| FY2007 Q4 | Dec 31 2007 | $38.78 | $3.49 | 11.1x | -69% |
| FY2007 Q3 | Sep 30 2007 | $40.77 | $2.76 | 14.8x | -59% |
| FY2007 Q2 | Jun 30 2007 | $38.39 | $5.83 | 6.6x | -82% |
| FY2007 Q1 | Mar 31 2007 | $34.56 | $4.74 | 7.3x | -80% |
| FY2006 Q4 | Dec 31 2006 | $34.09 | $4.11 | 8.3x | -77% |
| FY2006 Q3 | Sep 30 2006 | $31.76 | $4.06 | 7.8x | -78% |
| FY2006 Q2 | Jun 30 2006 | $28.25 | $1.80 | 15.7x | -56% |
| FY2006 Q1 | Mar 31 2006 | $30.53 | $2.30 | 13.3x | -63% |
| FY2005 Q4 | Dec 31 2005 | $28.21 | $2.26 | 12.5x | -65% |
| FY2005 Q3 | Sep 30 2005 | $24.20 | $2.26 | 10.7x | -70% |
| FY2005 Q2 | - | $22.85 | $2.04 | 11.2x | -69% |
| FY2005 Q1 | - | $24.97 | $1.76 | 14.2x | -61% |
| FY2004 Q4 | Dec 31 2004 | $24.04 | $2.08 | 11.6x | -68% |
| FY2004 Q3 | - | $20.78 | $2.16 | 9.6x | -73% |
| FY2004 Q2 | Jun 30 2004 | $24.68 | $1.40 | 17.6x | -51% |
| FY2004 Q1 | Mar 31 2004 | $26.29 | $0.98 | 26.8x | -25% |
| FY2003 Q4 | Dec 31 2003 | $26.39 | $0.53 | 49.7x | +38% |
| FY2001 Q3 | Sep 30 2001 | $17.51 | $1.02 | 17.1x | -52% |
Average P/E for displayed period: 35.9x
PHG Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
25+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PHG — Frequently Asked Questions
Quick answers to the most common questions about buying PHG stock.
What is PHG's P/E ratio?
Koninklijke Philips N.V. (PHG) trailing twelve-month P/E ratio is 23.1x, based on TTM diluted EPS of $1.15. The 5-year average P/E is 42.4x and the historical range spans 7.0x to 170.4x.
Is PHG stock overvalued or undervalued?
PHG trades at 23.1x P/E, below its 5-year average of 42.4x. At the 20th percentile of its historical range (7.0x–170.4x), the stock is priced at a discount to its own history.
Is PHG stock expensive?
No, PHG is not expensive on a historical basis. The current P/E of 23.1x is below the 5-year average of 42.4x and sits at the 20th percentile of its valuation range.
What is PHG's historical P/E range?
Over the past 5 years, PHG's P/E ratio has ranged from 7.0x to 170.4x, with a median of 33.4x and an average of 42.4x. The current P/E of 23.1x places the stock at the 20th percentile of this range. Full historical data spans 2001–2026.
How does PHG's P/E compare to the S&P 500?
PHG trades at 23.1x P/E versus the S&P 500 median of 25.3x. The 9% discount to the market suggests lower growth expectations or perceived higher risk.
How does PHG's valuation compare to Healthcare peers?
Koninklijke Philips N.V. P/E of 23.1x compares to the Healthcare sector median of 23.7x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is PHG's PEG ratio?
PHG PEG ratio is N/A, based on a P/E of 23.1x and EPS growth of 224.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is PHG's earnings yield?
PHG earnings yield is 4.33%, the inverse of its 23.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.